Solid Biosciences Inc.
NASDAQ:SLDB
5.66 (USD) • At close November 4, 2024
Overview | Financials
Numbers are in millions (except for per share data and ratios) USD.
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | |
|---|---|---|---|---|---|---|---|---|---|
| Assets: | |||||||||
| Current Assets: | |||||||||
| Cash & Cash Equivalents
| 74.015 | 155.384 | 119.136 | 154.744 | 76.043 | 86.366 | 52.08 | 7.678 | 28.595 |
| Short Term Investments
| 49.625 | 58.338 | 88.643 | 0 | 7.481 | 36.098 | 17.014 | 29.98 | 26.792 |
| Cash and Short Term Investments
| 123.64 | 213.722 | 207.779 | 154.744 | 83.524 | 122.464 | 69.094 | 37.658 | 55.387 |
| Net Receivables
| 0 | 0 | 0.11 | 0 | 0 | 0 | 0 | 0 | 0 |
| Inventory
| 0 | 0 | 6.015 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Current Assets
| 6.094 | 5.916 | 8.708 | 1.483 | 1.488 | 1.81 | 0.548 | 0.235 | 0.088 |
| Total Current Assets
| 129.734 | 219.638 | 222.612 | 158.901 | 86.302 | 128.639 | 70.658 | 39.972 | 55.696 |
| Non-Current Assets: | |||||||||
| Property, Plant & Equipment, Net
| 33.163 | 38.606 | 7.604 | 11.732 | 16.633 | 10.422 | 2.429 | 0.452 | 0 |
| Goodwill
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Intangible Assets
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Goodwill and Intangible Assets
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Long Term Investments
| 1.833 | 1.833 | 2.07 | 0.327 | 0.327 | 0 | 0 | 0 | 0 |
| Tax Assets
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Non-Current Assets
| 0.209 | 0.175 | 0.094 | 0.209 | 0.209 | 0.536 | 3.106 | 0.212 | 0 |
| Total Non-Current Assets
| 35.205 | 40.614 | 9.768 | 12.268 | 17.169 | 10.958 | 5.535 | 0.664 | 0 |
| Total Assets
| 164.939 | 260.252 | 232.38 | 171.169 | 103.471 | 139.597 | 76.193 | 40.636 | 55.696 |
| Liabilities & Equity: | |||||||||
| Current Liabilities: | |||||||||
| Account Payables
| 2.032 | 3.238 | 4.463 | 3.274 | 7.124 | 3.691 | 5.066 | 2.984 | 0.608 |
| Short Term Debt
| 2.324 | 2.565 | 1.495 | 2.207 | 1.922 | 0.173 | -0.233 | -0.345 | 0 |
| Tax Payables
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Deferred Revenue
| 0 | 0 | 8.08 | 10.359 | 9.178 | 8.235 | 0.233 | 0.345 | 0 |
| Other Current Liabilities
| 10.161 | 16.705 | 9.563 | 8.64 | 0.052 | 0.382 | 6.205 | 3.889 | 13.316 |
| Total Current Liabilities
| 14.517 | 22.508 | 23.601 | 24.48 | 18.276 | 12.481 | 11.271 | 6.873 | 13.924 |
| Non-Current Liabilities: | |||||||||
| Long Term Debt
| 23.941 | 25.982 | 0.568 | 2.944 | 5.147 | 0.859 | 0 | 0 | 0 |
| Deferred Revenue Non-Current
| 0 | 0 | 0 | 10.359 | 0 | 0 | 0 | 0 | 0 |
| Deferred Tax Liabilities Non-Current
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Non-Current Liabilities
| 0 | 0.096 | 0 | 1.3 | 0 | 1.074 | 124.179 | 71.649 | 61.697 |
| Total Non-Current Liabilities
| 23.941 | 26.078 | 0.568 | 14.603 | 5.147 | 1.933 | 124.179 | 71.649 | 61.697 |
| Total Liabilities
| 38.458 | 48.586 | 24.169 | 39.083 | 23.423 | 14.414 | 135.45 | 78.522 | 75.621 |
| Equity: | |||||||||
| Preferred Stock
| 0 | 0 | 0 | 0 | 0 | 139.597 | 124.179 | 71.649 | 61.697 |
| Common Stock
| 0.02 | 0.02 | 0.112 | 0.087 | 0.048 | 0.035 | 65.014 | 0.558 | 0.208 |
| Retained Earnings
| -658.753 | -562.738 | -476.757 | -404.569 | -316.279 | -199.056 | -124.258 | -84.941 | -67.711 |
| Accumulated Other Comprehensive Income/Loss
| 0.015 | -0.068 | -0.045 | 0 | 0.001 | -0.005 | -0.013 | 0.023 | -0.01 |
| Other Total Stockholders Equity
| 785.199 | 774.452 | 684.901 | 536.568 | 396.278 | 184.612 | -124.179 | -71.649 | -61.697 |
| Total Shareholders Equity
| 126.481 | 211.666 | 208.211 | 132.086 | 80.048 | 125.183 | -59.257 | -84.36 | -67.513 |
| Total Equity
| 126.481 | 211.666 | 208.211 | 132.086 | 80.048 | 125.183 | -59.257 | -37.886 | -19.925 |
| Total Liabilities & Shareholders Equity
| 164.939 | 260.252 | 232.38 | 171.169 | 103.471 | 139.597 | 76.193 | 40.636 | 55.696 |